The increasing demand for ketamine, primarily for emotional ailments, presents complex challenges regarding its sale and discreet transport within the United States. Strict federal laws govern this procedure, demanding adherence from vendors. Moreover, preserving customer confidentiality through thorough packaging and authorized logistics is essent